1-2 of 2
Sewanti A. Limaye
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A49: Viable circulating ensembles of tumor-associated cells persist in pretreated patients with solid organ cancers showing no radiologically detectable disease

Free
Sewanti A. Limaye, Timothy Crook, Dadasaheb Akolkar, Darshana Patil, Pradip Devhare, Revati Patil, Shoeb Patel, Shabista Khan, Raja Dhasarathan, Vineet Datta, Cynthe Sims, Ajay Srinivasan, Rajan Datar
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11_Supplement): A49.
https://doi.org/10.1158/1557-3265.LiqBiop20-A49
Published: 01 June 2020
View article titled, Abstract A49: Viable circulating ensembles of tumor-associated cells persist in pretreated patients with solid organ cancers showing no radiologically detectable disease
Journal Articles

Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study

Free
Glenn J. Hanna, Naifa L. Busaidy, Nicole G. Chau, Lori J. Wirth, Justine A. Barletta, Antonio Calles, Robert I. Haddad, Stefan Kraft, Maria E. Cabanillas, Guilherme Rabinowits, Anne O'Neill, Sewanti A. Limaye, Erik K. Alexander, Francis D. Moore, Jr, Krystof Misiwkeiwicz, Tom Thomas, Matthew Nehs, Ellen Marqusee, Stephanie L. Lee, Pasi A. Jänne, Jochen H. Lorch
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (7): 1546–1553.
https://doi.org/10.1158/1078-0432.CCR-17-2297
Published: 02 April 2018
View article titled, Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study
Open the PDF for Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study in another window
Includes: Supplementary data